Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirus. (2021)

First Author: Vlahava VM
Attributed to:  Utilising proteomics to develop anti-HCMV immunotherapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci139296

PubMed Identifier: 33586678

Publication URI: http://europepmc.org/abstract/MED/33586678

Type: Journal Article/Review

Volume: 131

Parent Publication: The Journal of clinical investigation

Issue: 4

ISSN: 0021-9738